News-Papers
Testimonial
Video Gallery
Search
Follow us...
Latest
- Melatonin inhibits growth of B16 melanoma in C57BL/6 mice
- Genomic vitamin D signaling in breast cancer: Insights from animal models and human cells
- Cancer and the potential place for growth hormone receptor antagonist therapy
- The expanding role of somatostatin analogs in gastroenteropancreatic and lung neuroendocrine tumors
- AKT pathway is activated by 1, 25-dihydroxyvitamin D3 and participates in its anti-apoptotic effect and cell cycle control in differentiating HL60 cells
- Melatonin enhances DNA repair capacity possibly by affecting genes involved in DNA damage responsive pathways
- Signal transduction of receptor-mediated antiproliferative action of melatonin on human prostate epithelial cells involves dual activation of Gα(s) and Gα(q) proteins
- Autocrine/paracrine regulation of breast cancer cell proliferation by growth hormone releasing hormone via Ras, Raf, and mitogen-activated protein kinase
- Long term increased expression of the short form 1b prolactin receptor in PC-3 human prostate cancer cells decreases cell growth and migration, and causes multiple changes in gene expression consistent with reduced invasive capacity
- Tocopherol and local X-ray irradiation of two transplantable rat tumours
- Melatonin cytotoxicity in human leukemia cells: relation with its pro-oxidant effect
- Cooperative interaction between retinoic acid receptor-alpha and estrogen receptor in breast cancer
- Phase I clinical trial repurposing all-trans retinoic acid as a stromal targeting agent for pancreatic cancer
- Myosin light chain kinase is a potential target for hypopharyngeal cancer treatment
- Evi1 Counteracts Anti-Leukemic and Stem Cell Inhibitory Effects of All-Trans Retinoic Acid on Flt3-ITD/ Npm1c-Driven Acute Myeloid Leukemia Cells
- Dose-dependent growth inhibition in vivo of PC-3 prostate cancer with a reduction in tumoral growth factors after therapy with GHRH antagonist MZ-J-7-138
- Effects of vitamin d and calcium on proliferation and differentiation in normal colon mucosa: a randomized clinical trial
- Prolactin as a chemoattractant for human breast carcinoma
Most Read
- The Di Bella Method (DBM)
- All-trans-retinoic acid and cancer
- About melatonin - 1996
- Biography
- The Di Bella Method Increases by the 30% the survival rate for Pancreas tumors and for this reason should be proposed as first line therapy for this type of cancer
- Bibliography
- Chronic Lymphocytic Leukemia: 4 patients, long-lasting remission
- Somatostatin in oncology, the overlooked evidences
- Non-Hodgkin's Lymphoma, Stage III-B-E: a Case Report
- Vademecum
- Large B-cells Non-Hodgkin's Lymphoma, Stage IV-AE: a Case Report
- How effective is chemo therapy?
- Frequently Asked Questions
- Treatment of Low-grade Non-Hodgkin’s Lymphomas at Advanced Stage
- Complete objective response to biological therapy of plurifocal breast carcinoma
- Declaration recommends eliminate the use of Impact factor for research evaluation
- Malignant pleural mesothelioma, stage T3-T4 - Consideration of a case study
- The melatonin deception